gland pharma glp-1 capacity expansion Q4 net profit slips 3% as US sales moderate; focus shifts to complex injectables, CDMO growth 🔥 Glenmark launches GLIPIQ® (Semaglutide)

Label: Ozempic oral semaglutide tablet and Rybelsus oral semaglutide tablet

Vitamin injections dont promise miracles

One of the most recent anti-obesity drugs, liraglutide, is a derivative of GLP-1 that stimulates the GLP-1 receptor

MC1R activation by MT-1 drives cAMP-PKA signalling that upregulates nucleotide excision repair enzymes, reduces cyclobutane pyrimidine dimer formation following UV challenge, activates antioxidant defence pathways, and suppresses UV-induced inflammatory cytokine production through NF-B inhibition

For people who want regulatory certainty and want to avoid injections entirely, this is currently the best value option in the brand-name category